+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Aneurysm Clips Market Size, Share & Industry Trends Analysis Report By Material, By End-use, By Indication, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 76 Pages
  • February 2023
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5752711
The North America Aneurysm Clips Market should witness market growth of 7.0% CAGR during the forecast period (2022-2028).

Clipping has been performed for a long time, that researches has been done on the basis of its results, and the procedure has been fine tuned for better outcomes. Clipping surgery could be carried out on most types of aneurysms, even for the already ruptured ones. The clipping process could also be done on those aneurysms that are considered challenging to treat, like those with a broad neck at the base.

Well-clipped aneurysms have a very low risk of reoccurrence, so for several patients, the clipping process resolves the issue of aneurysm. Due to these, most of the patients, especially the younger ones, prefer clipping surgery over any other treatment method which would stimulate the growth of the aneurysm clips market in the upcoming years.

The CDC stated, one out of six deaths from cardiovascular disease was because of stroke in 2020. More than 795,000 people in the U.S. undergo stroke every year. This indicates that stroke is the leading source of death for Americans. The WISEWOMAN program offers uninsured, underinsured, or low-income women with chronic disorder risk factor lifestyle programs, referral facilities, and screening to avoid strokes and heart disease. Such government initiatives and an increase in diseases like aneurysms and strokes will increase the utilization of aneurysm clips. These factors will surge the regional aneurysm clips market in the upcoming years.

The US market dominated the North America Aneurysm Clips Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $28,765.8 Thousands by 2028. The Canada market is poised to grow at a CAGR of 9.4% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 8.5% during (2022-2028).

Based on Material, the market is segmented into Titanium Aneurysm Clips, Polymer and Others. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on Indication, the market is segmented into Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Stryker Corporation, Integra LifeSciences Holdings Corporation, Boston Scientific Corporation, B. Braun Melsungen AG (Aesculap, Inc.), Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences), KLS Martin Group, Adeor Medical AG, and Evonos GmbH & Co.KG.

Scope of the Study

By Material

  • Titanium Aneurysm Clips
  • Polymer
  • Others

By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Indication

  • Stroke
  • Cerebral Artery Stenosis
  • Cerebral Aneurysm
  • Others

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players

List of Companies Profiled in the Report:

  • Medtronic PLC
  • Abbott Laboratories
  • Stryker Corporation
  • Integra LifeSciences Holdings Corporation
  • Boston Scientific Corporation
  • B. Braun Melsungen AG (Aesculap, Inc.)
  • Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
  • KLS Martin Group
  • Adeor Medical AG
  • Evonos GmbH & Co.KG

Unique Offerings

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Aneurysm Clips Market, by Material
1.4.2 North America Aneurysm Clips Market, by End-use
1.4.3 North America Aneurysm Clips Market, by Indication
1.4.4 North America Aneurysm Clips Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. North America Aneurysm Clips Market by Material
3.1 North America Titanium Aneurysm Clips Market by Country
3.2 North America Polymer Market by Country
3.3 North America Others Market by Country

Chapter 4. North America Aneurysm Clips Market by End-use
4.1 North America Hospitals Market by Country
4.2 North America Ambulatory Surgical Centers Market by Country
4.3 North America Others Market by Country

Chapter 5. North America Aneurysm Clips Market by Indication
5.1 North America Stroke Market by Country
5.2 North America Cerebral Artery Stenosis Market by Country
5.3 North America Cerebral Aneurysm Market by Country
5.4 North America Others Market by Country

Chapter 6. North America Aneurysm Clips Market by Country
6.1 US Aneurysm Clips Market
6.1.1 US Aneurysm Clips Market by Material
6.1.2 US Aneurysm Clips Market by End-use
6.1.3 US Aneurysm Clips Market by Indication
6.2 Canada Aneurysm Clips Market
6.2.1 Canada Aneurysm Clips Market by Material
6.2.2 Canada Aneurysm Clips Market by End-use
6.2.3 Canada Aneurysm Clips Market by Indication
6.3 Mexico Aneurysm Clips Market
6.3.1 Mexico Aneurysm Clips Market by Material
6.3.2 Mexico Aneurysm Clips Market by End-use
6.3.3 Mexico Aneurysm Clips Market by Indication
6.4 Rest of North America Aneurysm Clips Market
6.4.1 Rest of North America Aneurysm Clips Market by Material
6.4.2 Rest of North America Aneurysm Clips Market by End-use
6.4.3 Rest of North America Aneurysm Clips Market by Indication

Chapter 7. Company Profiles
7.1 Medtronic PLC
7.1.1 Company overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.1.6 SWOT Analysis
7.2 Abbott Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Stryker Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Integra LifeSciences Holdings Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental & Regional Analysis
7.4.4 Research & Development Expenses
7.5 Boston Scientific Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 B. Braun Melsungen AG (Aesculap, Inc.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.8 KLS Martin Group
7.8.1 Company Overview
7.9 Adeor Medical AG
7.9.1 Company Overview
7.10. Evonos GmbH & Co. KG
7.10.1 Company Overview

Companies Mentioned

  • Medtronic PLC
  • Abbott Laboratories
  • Stryker Corporation
  • Integra LifeSciences Holdings Corporation
  • Boston Scientific Corporation
  • B. Braun Melsungen AG (Aesculap, Inc.)
  • Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
  • KLS Martin Group
  • Adeor Medical AG
  • Evonos GmbH & Co.KG

Methodology

Loading
LOADING...